The German technology behemoth SAP SE has climbed to the top as Europe’s largest publicly traded company, overtaking the market valuation of the Danish pharmaceutical firm Novo Nordisk.
The global software firm headquartered in Walldorf, Baden-Württemberg, experienced an increase of over 1% in its stock price during early trading in Frankfurt. This boosted the company’s value, which had already surged by 40% in the last year, bringing its market capitalization close to approximately €312 billion.
“The present advancements in the stock market highlight the significant part played by tech firms in maintaining Europe’s competitiveness globally,” said an SAP representative to SANGGRALOKABusiness. “Our ongoing investments in cloud services, artificial intelligence, and innovation demonstrate SAP’s dedication to fostering digital transformation and sustainable expansion for enterprises across the world.”
At the same time, the drugmaker’s stock price in Copenhagen dropped over 2%, pushing the firm’s market capitalization slightly above 2.3 trillion Danish kroner (€309 billion). Despite announcing a 25% rise in revenues for 2024, the company’s share prices have plummeted nearly by half compared to last year’s levels.
Novo Nordisk gained prominence primarily because of its weight-loss medication, Wegovy, which drove the company’s stock prices upward until last summer when they reached approximately 1,000 Danish krone (€134). This was nearly twice their current value of 516 Danish krone.
However, the most recent updates regarding the findings of the company’s upcoming weight loss medication, CagriSema, seem discouraging since they did not demonstrate better outcomes than current treatments.
The doubt pulled down the stock price, which had already declined by approximately 16% this year.
In the meantime, the German technology firm won over its investors by adopting a strategy centered around subscription-based cloud services enhanced with advanced AI capabilities, projecting substantial increases in revenue.
JPMorgan recently stated that an “appealing buying chance has presented itself” regarding the SAP shares, noting that the investment firm’s analysts maintained their “Overweight” recommendation for the company’s stock along with setting a €300 price target.